Radiomics in glioma: emerging trends and challenges
Annals of Clinical and Translational Neurology · 2025-03 · 12 (3) · 460-477
DOI: 10.1002/acn3.52306 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 03.02.2025. Verfasst von Zihan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glioma, Brain Neoplasms, Neuroimaging, Deep Learning. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Science and Technology Project of Hebei Province, National Natural Science Foundation of China, Beijing Natural Science Foundation.
Abstract (Originalsprache)
Radiomics is a promising neuroimaging technique for extracting and analyzing quantitative glioma features. This review discusses the application, emerging trends, and challenges associated with using radiomics in glioma. Integrating deep learning algorithms enhances various radiomics components, including image normalization, region of interest segmentation, feature extraction, feature selection, and model construction and can potentially improve model accuracy and performance. Moreover, investigating specific tumor habitats of glioblastomas aids in a better understanding of glioblastoma aggressiveness and the development of effective treatment strategies. Additionally, advanced imaging techniques, such as diffusion‐weighted imaging, perfusion‐weighted imaging, magnetic resonance spectroscopy, magnetic resonance fingerprinting, functional MRI, and positron emission tomography, can provide supplementary information for tumor characterization and classification. Furthermore, radiomics analysis helps understand the glioma immune microenvironment by predicting immune‐related biomarkers and characterizing immune responses within tumors. Integrating multi‐omics data, such as genomics, transcriptomics, proteomics, and pathomics, with radiomics, aids the understanding of the biological significance of the underlying radiomics features and improves the prediction of genetic mutations, prognosis, and treatment response in patients with glioma. Addressing challenges, such as model reproducibility, model generalizability, model interpretability, and multi‐omics data integration, is crucial for the clinical translation of radiomics in glioma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
- Department of Neurosurgery, Guiqian International General Hospital, Guiyang, Guizhou, China.
ORCID-Profile: Lei Wang, Yinyan Wang
Förderung
- Science and Technology Project of Hebei Province
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
- Natural Science Foundation of Beijing Municipality
Zitieren
APA
Wang, Z., Wang, L., & Wang, Y. (2025). Radiomics in glioma: emerging trends and challenges. Annals of Clinical and Translational Neurology, 12(3), 460-477. https://doi.org/10.1002/acn3.52306
Vancouver
Wang Z, Wang L, Wang Y. Radiomics in glioma: emerging trends and challenges. Annals of Clinical and Translational Neurology. 2025;12(3):460-477. doi:10.1002/acn3.52306
BibTeX
@article{Wang2025,
author = {Wang, Zihan and Wang, Lei and Wang, Yinyan},
title = {Radiomics in glioma: emerging trends and challenges},
journal = {Annals of Clinical and Translational Neurology},
year = {2025},
volume = {12},
number = {3},
pages = {460--477},
doi = {10.1002/acn3.52306}
}
EUVIMED